DAIC

MAY 2, 2024

a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the primary endpoint results of the open label roll-in cohort of the CardiAMP Cell Therapy in Chronic Myocardial Ischemia Trial. Getty Images milla1cf Thu, 05/02/2024 - 10:12 May 2, 2024 — BioCardia, Inc. ,

Ischemia 95

Ischemia Angina Heart Failure Outcomes 95

DAIC

MARCH 27, 2025

ii to show blood flow through the heart muscle and evaluate the presence, extent and degree of myocardial ischemia or infarction. Around 6 million MPI procedures are undertaken each year in theU.S. Flyrcado is now available in selectU.S.markets.

Coronary Artery Disease 52

Coronary Artery Disease CMS Innovation Ischemia 52

DAIC

MARCH 3, 2025

Around six million MPI procedures are undertaken each year in the US [2] to show blood flow through the heart muscle and evaluate the presence, extent and degree of myocardial ischemia or infarction. National Center for Health Statistics. Multiple Cause of Death 20182022 on CDC WONDER Database.

Coronary Artery Disease 52

Coronary Artery Disease Ischemia Exercise Hospital 52

Journal of Clinical Investigation - Cardiology

DECEMBER 17, 2024

Myocardial infarction (MI) is characterized by massive cardiomyocyte (CM) death and cardiac dysfunction, and effective therapies to achieve cardioprotection are greatly needed. Here, we report that flavin-containing monooxygenase 2 (FMO2) levels were markedly increased in CMs in both ex vivo and in vivo models of ischemic injury.

CMS 52

CMS Ischemia Myocardial Infarction Heart Disease 52

Circulation

MARCH 18, 2025

Here, we aimed to evaluate the role and mechanism of Nrf3 in injury-induced pathological cardiac remodeling.METHODS:Global (Nrf3-KO) and CM-specific (Nrf3CM) Nrf3 knockout mice were subjected to MI or ischemia/reperfusion injury, followed by functional and histopathological analysis.

Cardiac Function 45

Cardiac Function CMS Ischemia Circulation 45